MARTHA FLORES: Open Payments
NPI 1194460014 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 21 payments from 8 companies in 2025. Trend: 2023 $1,326 · 2024 $994 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $210 |
| Viatris Specialty LLC | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Grifols USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $14 |
Products named: TEZSPIRE, YUPELRI, FASENRA, Prolastin-C Liquid, TRELEGY ELLIPTA, OFEV, ACTHAR, NUCALA.
Industry payments across TX — which companies pay providers there.
